WallStSmart
CMND

Clearmind Medicine Inc. Common Shares

NASDAQ: CMND · HEALTHCARE · BIOTECHNOLOGY

$0.70
-5.61% today

Updated 2026-04-29

Market cap
$1.94M
P/E ratio
P/S ratio
EPS (TTM)
$-24.12
Dividend yield
52W range
$1 – $52
Volume
5.8M

Clearmind Medicine Inc. Common Shares (CMND) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$0.00$0.00$0.00$2527.00$119616.00$79064.00$71092.00$49364.00
Gross profit$0.00$0.00$0.00$-2527.00$-119616.00$-79064.00$-71092.00$-49364.00
Gross margin
R&D$0.00$635404.00$4.42M$2.11M$1.91M$2.05M
SG&A$33233.00$46857.00$24215.00$254535.00$105283.00$233220.00$3.03M$5.43M$6.60M$3.26M$3.57M
Operating income$-33233.00$-46857.00$-24215.00$-6529.00$-254535.00$-105283.00$-233220.00$-3.61M$-9.00M$-8.67M$-8.00M$-5.67M
Operating margin
EBITDA$-6529.00$-254535.00$-105283.00$-233220.00$-3.65M$-9.75M$-11.75M$-6.67M$-3.72M
EBITDA margin
EBIT$-33233.00$-46857.00$-24215.00$-6670.00$-254535.00$-105283.00$-233220.00$-3.66M$-9.86M$-11.83M$-6.74M$-3.77M
Interest expense$0.00$0.00$0.00$0.00$446436.00$20759.00$10894.00$50336.00$19535.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-33233.00$-46857.00$-24215.00$-6529.00$-194535.00$-105283.00$-233220.00$-3.66M$-9.93M$-11.85M$-7.31M$-3.86M
Net income growth (YoY)-41.0%+48.3%+73.0%-2879.6%+45.9%-121.5%-1467.6%-171.6%-19.4%+38.3%+47.3%
Profit margin